Florida endocrine symposium set for Tampa Oct. 23-24

The Florida Endocrine Tumor Symposium will bring about 100 to 150 clinicians to Tampa Oct. 23-24 for CME-accredited, case-based training on thyroid, parathyroid and adrenal disease. The program is designed to give physicians direct access to national and international experts and practical updates on emerging treatments.

Why it matters: - The symposium is aimed at clinicians who treat endocrine tumors and could use practical updates on diagnosis and surgery for thyroid, parathyroid and adrenal disease. - Organizers say the smaller format is meant to increase direct faculty access, multidisciplinary discussion and networking. - Attendees may earn 7.5 AMA PRA Category 1 Credits.

What happened: - Registration is open for the Florida Endocrine Tumor Symposium, or FETS, a CME-accredited meeting in Tampa, Florida, on Oct. 23-24, 2026. - The event opens Friday evening with a reception at the Hospital for Endocrine Surgery and continues Saturday with a full day of scientific programming. - The symposium is designed for endocrinologists, endocrine and head and neck surgeons, oncologists, primary care physicians, fellows, advanced practice providers, nurse practitioners and other healthcare professionals involved in endocrine tumor care.

The details: - The meeting is built around case-based education on thyroid, parathyroid and adrenal disease. - The conference is expected to draw about 100 to 150 clinicians. - Featured faculty include Constantine A. Stratakis, MD, D(Med)Sci; Steven I. Sherman, MD; Tobias Carling, MD, PhD; Jamie Mitchell, MD; Gary Clayman, MD; Eyas Alkhalili, MD; Valentina Tarasova, MD; Tae-Yon Sung, MD; Manuel C. Sainz de la Pena, MD; and Jesus L. Penabad, MD. - Saturday sessions will cover recurrent and persistent primary hyperparathyroidism, adrenal hypercortisolism and Cushing syndrome, function-preserving adrenal surgery, osteoporosis in endocrine tumor disease, molecular diagnostics for thyroid nodules, advanced thyroid cancer surgery, robotic thyroid surgery, and targeted therapies and immunotherapy for advanced thyroid cancer. - Fellow case presentations and an interactive faculty Q&A are also part of the program. - Two keynote talks are scheduled: Constantine Stratakis will discuss adrenal hypercortisolism from MACS to severe Cushing syndrome, and Steven I. Sherman of MD Anderson Cancer Center will cover targeted therapies and immunotherapy for advanced thyroid cancer. - The Friday reception includes a hospital tour, faculty meet-and-greet and networking over cocktails and hors d'oeuvres. - Transportation from the conference host hotel will be provided. - The Florida Endocrine Tumor Symposium website has the complete scientific program and registration details: Additional conference information.

Between the lines: - The event is positioning itself as a boutique alternative to a large national congress, which may appeal to specialists who want more direct discussion time with faculty. - The focus on case presentations and emerging therapies suggests the program is aimed at translating research into bedside and operating-room decisions. - The hospital venue is being used as part of the experience, reinforcing the conference's surgical and specialty-care identity.

What's next: - Organizers are encouraging early registration because of the limited size. - The symposium will take place Oct. 23-24, 2026, in Tampa. - Additional program updates and logistical details are available on the conference website.